{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "None", "lead_paragraph": "Too-thin models, too much drinking, sexy cigarette packs: France's parliament is cracking down on all of these in a sweeping bill designed to improve public health and trim public health costs &#8212; while tackling unhealthy stereotypes along the way.", "headline": {"main": "French Lawmakers OK Health Care Bill Targeting Anorexia", "print_headline": "French Lawmakers OK Health Care Bill Targeting Anorexia"}, "abstract": null, "print_page": null, "word_count": "644", "_id": "552d36a1798810155ad44e06", "snippet": "Too-thin models, too much drinking, sexy cigarette packs: France's parliament is cracking down on all of these in a sweeping bill designed to improve public health and trim public health costs &#8212; while tackling unhealthy stereotypes along the...", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2015/04/14/world/europe/ap-eu-france-health.html", "multimedia": [], "subsection_name": "Europe", "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2015-04-14T11:45:26Z", "section_name": "World"}, {"type_of_material": "News", "blog": [], "news_desk": "None", "lead_paragraph": "Johnson &amp; Johnson's first-quarter profit uncharacteristically fell 8.6 percent, hurt by sharply unfavorable exchange rates, a major divestiture and competition to its new hepatitis C drug.", "headline": {"main": "Johnson &amp; Johnson Profit Beats Forecasts", "print_headline": "Johnson & Johnson Beats Street 1Q Forecasts"}, "abstract": null, "print_page": null, "word_count": "506", "_id": "552d027a798810155ad44d45", "snippet": "Johnson &amp; Johnson's first-quarter profit uncharacteristically fell 8.6 percent, hurt by sharply unfavorable exchange rates, a major divestiture and competition to its new hepatitis C drug.", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/aponline/2015/04/14/business/ap-us-earns-johnson-johnson.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "document_type": "article", "pub_date": "2015-04-14T08:01:05Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "The latest salvo in a four-year battle with Teladoc, a national company that provides telephone or video consultations with doctors.", "headline": {"main": "Texas Medical Panel Votes to Limit Telemedicine Practices in State", "print_headline": "Texas Medical Panel Votes to Limit Telemedicine Practices in State"}, "abstract": "Texas Medical Board, which licenses and regulates physicians in state, votes to sharply restrict use of telemedicine; is latest move in four-year battle with Dallas-based Teladoc, which provides telephone or video consultations with staff doctors for routine medical problems; while many states are supporting such services in effort to increase access to medical care under Affordable Care Act, Texas has moved in opposite direction.", "print_page": "9", "word_count": "1044", "_id": "55286a1679881039ac5efbd6", "snippet": "The latest salvo in a four-year battle with Teladoc, a national company that provides telephone or video consultations with doctors.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2015/04/11/us/texas-medical-panel-votes-to-limit-telemedicine-practices-in-state.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Telemedicine", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Texas", "is_major": "Y", "rank": "2", "name": "glocations"}, {"value": "Teladoc Inc", "is_major": "Y", "rank": "3", "name": "organizations"}, {"value": "Medicine and Health", "is_major": "Y", "rank": "4", "name": "subject"}, {"value": "Doctors", "is_major": "Y", "rank": "5", "name": "subject"}, {"value": "Patient Protection and Affordable Care Act (2010)", "is_major": "Y", "rank": "6", "name": "subject"}, {"value": "Texas Medical Board", "is_major": "N", "rank": "7", "name": "organizations"}, {"value": "Regulation and Deregulation of Industry", "is_major": "N", "rank": "8", "name": "subject"}], "byline": {"contributor": "David Montgomery contributed reporting.", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Abby", "lastname": "GOODNOUGH"}], "original": "By ABBY GOODNOUGH"}, "document_type": "article", "pub_date": "2015-04-11T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "Blog", "blog": [], "news_desk": "OpEd", "lead_paragraph": null, "headline": {"main": "Overruling My Father", "kicker": "The End"}, "abstract": "He thought it was wrong to treat infections in terminally ill patients, until it was his turn.", "print_page": null, "word_count": "886", "_id": "55250a847988102f94b8c461", "snippet": "He thought it was wrong to treat infections in terminally ill patients, until it was his turn.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://opinionator.blogs.nytimes.com/2015/04/08/overruling-my-father/", "multimedia": [{"subtype": "wide", "url": "images/2015/01/30/opinion/opinionator-theend-series-icon/opinionator-theend-series-icon-thumbWide.png", "height": 126, "width": 190, "legacy": {"wide": "images/2015/01/30/opinion/opinionator-theend-series-icon/opinionator-theend-series-icon-thumbWide.png", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2015/01/30/opinion/opinionator-theend-series-icon/opinionator-theend-series-icon-articleLarge.png", "height": 600, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2015/01/30/opinion/opinionator-theend-series-icon/opinionator-theend-series-icon-articleLarge.png", "xlargeheight": "600"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2015/01/30/opinion/opinionator-theend-series-icon/opinionator-theend-series-icon-thumbStandard.png", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2015/01/30/opinion/opinionator-theend-series-icon/opinionator-theend-series-icon-thumbStandard.png", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Antibiotics", "name": "subject", "rank": "1"}, {"value": "Death and Dying", "name": "subject", "rank": "2"}], "byline": {"person": [{"firstname": "Barron", "middlename": "H.", "lastname": "LERNER", "rank": 1, "role": "reported", "organization": ""}], "original": "By BARRON H. LERNER"}, "document_type": "blogpost", "pub_date": "2015-04-08T07:00:18Z", "section_name": "Opinion"}], "meta": {"hits": 4, "offset": 0, "time": 22}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}